✓ Betalning med kreditkort återställd — säker kassahantering via Privacy Shield

Artesunate

Artesunate (50/60/120 mg) — artemisinin-derivative antimalarial. WHO first-line IV for severe falciparum malaria; oral artesunate combinations for uncomplicated malaria.

Artikelnummer: Artesunate Kategori: , ,

Medicinskt granskad av Morgan Ellis — Apoteksforskare · 8 års erfarenhet  · Senast granskad: maj 2026

Krypterad kassa
Kryptobetalning ger 10% rabatt
Diskret världsomspännande leverans
1 400+ kunder · 50+ länder

Denna produkt är för närvarande slut i lager och inte tillgänglig.

Quick Answer

Artesunate — Artesunate 50/60/120 mg (WHO-GMP certified manufacturer). Artemisinin derivative for severe falciparum malaria (IV first-line WHO recommendation), uncomplicated malaria (oral artesunate-mefloquine combinations), occasional research use in oncology (off-label, unproven).

Vad du får med MedsBase:

  • WHO-GMP-certifierad tillverkare
  • Diskret förpackning i vanligt kuvert
  • Världsvid leverans
  • Betygsatt av 1 400+ kunder (läs recensioner)

📦 Reshipment Assurance: om din order inte har anlänt 20 arbetsdagar efter försändelse, skickar vi en ny utan extra kostnad. Läs policyn.

Varför beställa från MedsBase

Artesunate ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.

Antimalarial — primary indication
Artesunate is a first-line antimalarial agent. Off-label cancer research is investigational and not standard care. For severe malaria, IV artesunate replaced quinine as WHO first-line in 2010 (SEAQUAMAT, AQUAMAT trials). Specialist infectious disease supervision for severe disease.

Vanliga frågor

When is this used?

Artemisinin derivative for severe falciparum malaria (IV first-line WHO recommendation), uncomplicated malaria (oral artesunate-mefloquine combinations), occasional research use in oncology (off-label, unproven).

Biverkningar?

Class-specific — see safety boxes above. Most supportive cancer medications are well-tolerated when used per protocol but require specialist supervision.

Läkemedelsinteraktioner?

Always disclose all medications. Cancer supportive therapy interacts with multiple cytotoxics, chemo regimens, and concomitant medications.

Graviditet?

Variable by molecule. Consult oncology for pregnancy planning during cancer therapy.

Monitoring?

Specialist-determined — typically FBC, electrolytes, renal/liver function, cardiac monitoring as relevant.

Vad händer om jag missar en dos?

Take when you remember; do not double up. Discuss with oncology team if multiple doses missed.

When is treatment finished?

Determined by clinical response, planned regimen length, and patient tolerance.

Förvaring?

Per package insert — typically below 25-30°C, away from light and moisture. Pregnant household members should not handle broken tablets/capsules.

Cost?

Generic Indian biosimilars and chemical equivalents are dramatically less expensive than originator products with documented bioequivalence and clinical equivalence.

Vaccines?

Coordinate with oncology — live vaccines may be contraindicated during cancer therapy.

Other Cancer & Supportive Medications

  • Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
  • Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
  • Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
  • Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
  • Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
Medicinsk ansvarsfriskrivning: Cancer therapy is highly individualised. Specific drug, dose, schedule, monitoring, and supportive care must be determined by a qualified oncologist or haematologist based on tumour biology, staging, comorbidities, and goals of care. This information is educational; it does not substitute for professional medical advice.

More options in Anti Cancer Medication

Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.

Styrka

50 mg

Kvantitet

32 Tablet/s, 64 Tablet/s, 92 Tablet/s

Farmaceutisk form

Tabletter

Tillverkare

Troikaa Pharma

Behandling

Malaria

Generiskt märke

Artesunate

Recensioner

Det finns inga recensioner än

Skriv en recension
Artesunate Artesunate
Betyg*
0/5
* Betyg är obligatoriskt
* Svar är obligatoriskt
Din recension
* Recension är obligatorisk
Namn
* Namn är obligatoriskt
Lägg till foton eller video i din recension

Frågor & svar

Ställ en fråga
Artesunate Artesunate
Din fråga
* Fråga är obligatorisk
Namn
* Namn är obligatoriskt
Det finns inga frågor än